Kaiwu Xu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Top Venues

ImmunoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kaiwu Xu, Cailing Xiang, Zhige Yu, Jia Li, Changjun Liu
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis. ImmunoTargets and therapy 13 (2024)
Kaiwu Xu, Cailing Xiang, Zhige Yu, Jia Li, Changjun Liu
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis. ImmunoTargets and therapy 13 (2024)